GCL
PROK icon

Glazer Capital LLC’s ProKidney PROK Stock Holding History

Glazer Capital LLC’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-279,519
Closed -$2.77M – 604
2021
Q4 		$2.77M Sell
279,519
-186,065
-40% -$1.84M 0.07% 299
2021
Q3 		$4.56M Buy
465,584
+40,584
+10% +$400K 0.08% 274
2021
Q2 		$4.3M Buy
+425,000
New +$4.3M 0.07% 323

Other funds holding PROK

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Glazer Capital LLC's PROK Position: Q1 2022 in Review

Glazer Capital LLC sold out of ProKidney (PROK) in Q1 2022, closing a stake of 279,519 shares — an estimated $2.77M sold.

Glazer Capital LLC first reported a position in PROK in Q2 2021 and held it in 3 quarters. The position peaked at $4.56M in Q3 2021. 80 funds tracked by Wall St. Rank hold PROK as of Q1 2022.

  • Glazer Capital LLC reported no remaining ProKidney position as of Q1 2022 after selling out during the quarter.
  • Glazer Capital LLC sold 279,519 ProKidney shares in Q1 2022, an estimated $2.77M.
  • Glazer Capital LLC first reported a position in ProKidney in Q2 2021 and held it in 3 quarters.
  • Glazer Capital LLC's ProKidney position peaked at $4.56M in Q3 2021.
  • 80 funds tracked by Wall St. Rank held ProKidney as of Q1 2022.

Based on Glazer Capital LLC's 13F filing for Q1 2022, filed 17 May 2022.